---
document_datetime: 2023-09-21 21:06:28
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/quviviq-epar-all-authorised-presentations_en.pdf
document_name: quviviq-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.3482545
conversion_datetime: 2025-12-19 00:30:05.387309
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
## MA (EU) number (Invented) name Strength Pharmaceutical Form Route of Administration Immediate Packaging Pack size

EU/1/22/1638/001 QUVIVIQ 25 mg Film-coated tablet Oral use blister (PVC/PVDC/PVC/alu) 10 tablets EU/1/22/1638/002 QUVIVIQ 25 mg Film-coated tablet Oral use blister (PVC/PVDC/PVC/alu) 30 tablets EU/1/22/1638/003 QUVIVIQ 50 mg Film-coated tablet Oral use blister (PVC/PVDC/PVC/alu) 10 tablets EU/1/22/1638/004 QUVIVIQ 50 mg Film-coated tablet Oral use blister (PVC/PVDC/PVC/alu) 30 tablets EU/1/22/1638/005 QUVIVIQ 25 mg Film-coated tablet Oral use blister (PVC/PVDC/PVC/alu) 20 tablets EU/1/22/1638/006 QUVIVIQ 50 mg Film-coated tablet Oral use blister (PVC/PVDC/PVC/alu) 20 tablets